logo

For the Inventor, By the Inventor

Seoul, South Korea

Cj Healthcare Corporation

Calculating rank
USPTO Granted Patents = 14

% Expired Patents = 7.1



Trademarks = 2

Forward Citations = 42

Loading Chart...
Loading Chart...

87 inventors (with patents filed for the assignee):

goldMedal Young Joon Park (6 out of 7 patents)

silverMedal Dong Hyun Ko (4 out of 12 patents)

bronzeMedal Chi Hye Park (3 out of 3 patents)

4.  Seog Beom Song (3 out of 4 patents)

5.  Ha Yong Choi (3 out of 3 patents)

6.  Nak Hyun Choi (3 out of 3 patents)

7.  Jae Hong Kweon (2 out of 5 patents)

8.  Kwang Do Choi (2 out of 13 patents)

9.  Shin-Young Ryu (2 out of 2 patents)

10.  Hyoung Rok Bak (2 out of 2 patents)

11.  Won-Hyuk Jung (2 out of 3 patents)

12.  Eun Sun Kim (2 out of 168 patents)

13.  Hoo Keun Oh (2 out of 2 patents)

14.  Chung Min Lee (2 out of 2 patents)

15.  Sun Kyung Lim (2 out of 2 patents)


14 patents:

1. 11202783 - Use of aminoalkylbenzothiazepine derivatives (2021-12-21),
2. 10723775 - Method for purifying darbepoetin alfa (2020-07-28),
3. 10512635 - Uses of benzimidazole derivative for nocturnal acid breakthrough (2019-12-24),
4. 10195149 - Continuous process for preparing microspheres and microspheres prepared thereby (2019-02-05),
5. 10047041 - Amino-phenyl-sulfonyl-acetate derivatives and use thereof (2018-08-14),
6. 9908870 - Crystalline form of a benzimidazole derivative and a preparation method thereof (2018-03-06),
7. 9902753 - Method of purifying a long-acting human growth hormone (2018-02-27),
8. 9890129 - Aminoalkylbenzothiazepine derivatives and uses thereof (2018-02-13),
9. 9687482 - Stable pharmaceutical composition comprising solifenacin, and method for preparing the same (2017-06-27),
10. 9629844 - Stabilized pemetrexed formulation (2017-04-25),
11. 9539213 - Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby (2017-01-10),
12. 9493425 - Method for preparation of benzimidazole derivatives (2016-11-15),
13. 9265832 - Stabilized pemetrexed formulation (2016-02-23),
14. D739256 - Bottle (2015-09-22),
Company Overview
Cj Healthcare Corporation is a prominent South Korean company specializing in the development and manufacturing of pharmaceuticals and biopharmaceuticals. With a focus on innovative healthcare solutions, the company is dedicated to improving patient outcomes through advanced research in therapeutic areas such as oncology, cardiology, and neurology. Cj Healthcare leverages cutting-edge technology and a commitment to quality to deliver effective treatments, contributing to the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#296 in Seoul

#826 in South Korea

#42,312 in the World

Seoul, KR
Seoul, South Korea

Cj Healthcare Corporation

Forward Citations = 42

87 inventors:

goldMedal Young Joon Park (6 out of 7 patents)

silverMedal Dong Hyun Ko (4 out of 12 patents)

bronzeMedal Chi Hye Park (3 out of 3 patents)

4.  Seog Beom Song (3 out of 4 patents)

5.  Ha Yong Choi (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cj Healthcare Corporation. Retrieved from https://idiyas.com/company/cj-healthcare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…